$ARNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARENA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARENA PHARMACEUTICALS INC. Get notifications about new insider transactions in ARENA PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Knobil Katharine | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Knobil Katharine | Director | Grant | A | 0.00 | 3,067 | 0 | 6,821 | 3.8 K to 6.8 K (+81.70 %) |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 3,067 | 0 | 9,283 | 6.2 K to 9.3 K (+49.34 %) |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 3,067 | 0 | 11,217 | 8.2 K to 11.2 K (+37.63 %) |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Schoch Steven J | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Schoch Steven J | Director | Option Exercise | A | 65.19 | 3,601 | 234,749 | 3,601 | |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Schoch Steven J | Director | Grant | A | 0.00 | 3,067 | 0 | 4,600 | 1.5 K to 4.6 K (+200.07 %) |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Schoch Steven J | Director | Grant | A | 0.00 | 1,533 | 0 | 1,533 | 0 to 1.5 K |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 3,067 | 0 | 11,217 | 8.2 K to 11.2 K (+37.63 %) |
Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 12,600 | 0 | 0 | |
Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Payment of Exercise | F | 76.10 | 4,356 | 331,492 | 14,904 | 19.3 K to 14.9 K (-22.62 %) |
Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Buy | M | 0.00 | 12,600 | 0 | 19,260 | 6.7 K to 19.3 K (+189.19 %) |
Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | M | 0.00 | 12,600 | 0 | 0 | |
Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Payment of Exercise | F | 77.58 | 4,874 | 378,125 | 14,601 | 19.5 K to 14.6 K (-25.03 %) |
Apr 02 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Buy | M | 0.00 | 12,600 | 0 | 19,475 | 6.9 K to 19.5 K (+183.27 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Grant | A | 0.00 | 6,660 | 0 | 6,660 | 0 to 6.7 K |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 0.00 | 42,000 | 0 | 42,000 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 80.08 | 168,000 | 13,453,440 | 168,000 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Grant | A | 0.00 | 28,800 | 0 | 36,550 | 7.8 K to 36.6 K (+371.61 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Grant | A | 0.00 | 6,660 | 0 | 6,875 | 215 to 6.9 K (+3,097.67 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Grant | A | 0.00 | 6,660 | 0 | 6,875 | 215 to 6.9 K (+3,097.67 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,660 | 0 | 16,101 | 9.4 K to 16.1 K (+70.54 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,660 | 0 | 16,101 | 9.4 K to 16.1 K (+70.54 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Grant | A | 0.00 | 6,660 | 0 | 33,660 | 27 K to 33.7 K (+24.67 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Grant | A | 0.00 | 6,660 | 0 | 33,660 | 27 K to 33.7 K (+24.67 %) |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Ouzren Nawal | Director | Option Exercise | A | 83.95 | 1,666 | 139,861 | 1,666 | |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Ouzren Nawal | Director | Option Exercise | A | 83.95 | 2,500 | 209,875 | 2,500 | |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Ouzren Nawal | Director | Grant | A | 0.00 | 595 | 0 | 1,488 | 893 to 1.5 K (+66.63 %) |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Ouzren Nawal | Director | Grant | A | 0.00 | 893 | 0 | 893 | 0 to 893 |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 24 | 854 | 94,976 | |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 2,500 | 36,500 | 77,000 | |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 85.00 | 2,524 | 214,540 | 27,000 | 29.5 K to 27 K (-8.55 %) |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 24 | 854 | 29,524 | 29.5 K to 29.5 K (+0.08 %) |
Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 2,500 | 36,500 | 29,500 | 27 K to 29.5 K (+9.26 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 40.95 | 17,500 | 716,625 | 127,500 | |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 79.35 | 9,359 | 742,637 | 9,441 | 18.8 K to 9.4 K (-49.78 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 78.50 | 6,400 | 502,394 | 18,800 | 25.2 K to 18.8 K (-25.40 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 77.70 | 1,741 | 135,278 | 25,200 | 26.9 K to 25.2 K (-6.46 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 40.95 | 17,500 | 716,625 | 26,941 | 9.4 K to 26.9 K (+185.36 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 80.50 | 1,327 | 106,824 | 5,308 | 6.6 K to 5.3 K (-20.00 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 138,139 | |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 188,139 | |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 80.14 | 50,000 | 4,006,760 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 81.06 | 2,900 | 235,060 | 7,750 | 10.7 K to 7.8 K (-27.23 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 80.19 | 47,100 | 3,776,916 | 10,650 | 57.8 K to 10.7 K (-81.56 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 80.50 | 1,327 | 106,824 | 5,308 | 6.6 K to 5.3 K (-20.00 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 138,139 | |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 188,139 | |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 80.14 | 50,000 | 4,006,760 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 81.06 | 2,900 | 235,060 | 7,750 | 10.7 K to 7.8 K (-27.23 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 80.19 | 47,100 | 3,776,916 | 10,650 | 57.8 K to 10.7 K (-81.56 %) |
Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 12,600 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 77.59 | 3,159 | 245,107 | 9,441 | 12.6 K to 9.4 K (-25.07 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 12,600 | 0 | 12,600 | 0 to 12.6 K |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 18,000 | 0 | 27,000 | 9 K to 27 K (+200.00 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 0.00 | 23,400 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Payment of Exercise | F | 77.59 | 8,523 | 661,300 | 22,627 | 31.2 K to 22.6 K (-27.36 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 0.00 | 23,400 | 0 | 31,150 | 7.8 K to 31.2 K (+301.94 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 12,600 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 77.59 | 3,159 | 245,107 | 9,441 | 12.6 K to 9.4 K (-25.07 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 12,600 | 0 | 12,600 | 0 to 12.6 K |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 18,000 | 0 | 27,000 | 9 K to 27 K (+200.00 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 0.00 | 23,400 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Payment of Exercise | F | 77.59 | 8,523 | 661,300 | 22,627 | 31.2 K to 22.6 K (-27.36 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 0.00 | 23,400 | 0 | 31,150 | 7.8 K to 31.2 K (+301.94 %) |
Dec 15 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Buy | P | 69.31 | 5 | 347 | 6,635 | 6.6 K to 6.6 K (+0.08 %) |
Dec 09 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Buy | P | 66.25 | 5 | 331 | 6,630 | 6.6 K to 6.6 K (+0.08 %) |
Dec 09 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 70.00 | 6,517 | 456,198 | 7,750 | 14.3 K to 7.8 K (-45.68 %) |
Dec 03 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 66.72 | 550 | 36,697 | 0 | 550 to 0 (-100.00 %) |
Dec 03 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 66.06 | 3,022 | 199,629 | 550 | 3.6 K to 550 (-84.60 %) |
Dec 03 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 64.87 | 300 | 19,460 | 3,572 | 3.9 K to 3.6 K (-7.75 %) |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 6,300 | 0 | 12,600 | |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 65.50 | 2,428 | 159,034 | 3,872 | 6.3 K to 3.9 K (-38.54 %) |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 6,300 | 0 | 6,300 | 0 to 6.3 K |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Payment of Exercise | F | 65.50 | 1,099 | 71,985 | 1,401 | 2.5 K to 1.4 K (-43.96 %) |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 9,000 | 0 | 18,000 | |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 0.00 | 11,700 | 0 | 23,400 | |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Payment of Exercise | F | 65.50 | 5,183 | 339,487 | 14,267 | 19.5 K to 14.3 K (-26.65 %) |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 0.00 | 11,700 | 0 | 19,450 | 7.8 K to 19.5 K (+150.97 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 238,139 | |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 238,139 | |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 288,139 | |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | M | 15.50 | 50,000 | 775,000 | 288,139 | |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 70.10 | 50,000 | 3,505,035 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 70.10 | 50,000 | 3,505,035 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 70.00 | 50,000 | 3,500,000 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Sell | S | 70.00 | 50,000 | 3,500,000 | 7,750 | 57.8 K to 7.8 K (-86.58 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Aug 31 2020 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Buy | M | 15.50 | 50,000 | 775,000 | 57,750 | 7.8 K to 57.8 K (+645.16 %) |
Aug 28 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | M | 20.00 | 12,500 | 250,000 | 0 | |
Aug 28 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | M | 12.70 | 3,600 | 45,720 | 0 | |
Aug 28 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | M | 14.90 | 1,200 | 17,880 | 0 | |
Aug 28 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Sell | S | 67.94 | 17,300 | 1,175,303 | 16,576 | 33.9 K to 16.6 K (-51.07 %) |
Aug 28 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Buy | M | 20.00 | 12,500 | 250,000 | 33,876 | 21.4 K to 33.9 K (+58.48 %) |
Aug 28 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Buy | M | 12.70 | 3,600 | 45,720 | 21,376 | 17.8 K to 21.4 K (+20.25 %) |
Aug 28 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Buy | M | 14.90 | 1,200 | 17,880 | 17,776 | 16.6 K to 17.8 K (+7.24 %) |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 40.95 | 30,000 | 1,228,500 | 115,000 | |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 63.58 | 22,575 | 1,435,298 | 0 | 22.6 K to 0 (-100.00 %) |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 62.63 | 7,425 | 465,047 | 22,575 | 30 K to 22.6 K (-24.75 %) |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 40.95 | 30,000 | 1,228,500 | 30,000 | 0 to 30 K |
Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | M | 26.28 | 13,000 | 341,640 | 47,000 | |
Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Sell | S | 68.00 | 13,000 | 884,000 | 0 | 13 K to 0 (-100.00 %) |
Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Buy | M | 26.28 | 13,000 | 341,640 | 13,000 | 0 to 13 K |
Jun 18 2020 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Sell | S | 62.74 | 304 | 19,073 | 5,902 | 6.2 K to 5.9 K (-4.90 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Grant | A | 0.00 | 2,446 | 0 | 16,576 | 14.1 K to 16.6 K (+17.31 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 2,446 | 0 | 8,150 | 5.7 K to 8.2 K (+42.88 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 2,446 | 0 | 8,150 | 5.7 K to 8.2 K (+42.88 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 2,446 | 0 | 9,844 | 7.4 K to 9.8 K (+33.06 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | FETZER OLIVER | Director | Grant | A | 0.00 | 2,446 | 0 | 6,625 | 4.2 K to 6.6 K (+58.53 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Grant | A | 0.00 | 2,446 | 0 | 6,625 | 4.2 K to 6.6 K (+58.53 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Knobil Katharine | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Knobil Katharine | Director | Option Exercise | A | 61.31 | 2,500 | 153,275 | 2,500 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Knobil Katharine | Director | Grant | A | 0.00 | 2,446 | 0 | 3,754 | 1.3 K to 3.8 K (+187.00 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Knobil Katharine | Director | Grant | A | 0.00 | 1,223 | 0 | 1,308 | 85 to 1.3 K (+1,438.82 %) |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | A | 61.31 | 20,000 | 1,226,200 | 20,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Soni Manmeet Singh | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 |